We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

News   Mar 05, 2018 | Original story from Owstone Medical

 
Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

Billy Boyle, CEO, Owlstone Medical

 
 
 

RELATED ARTICLES

A Novel Epstein-Barr Virus-specific T Cell Therapy for Progressive MS

News

Mounting evidence shows that Epstein-Barr virus (EBV) plays a role in the pathology of multiple sclerosis. Consequently, an EBV-specific T Cell therapy has been developed to combat MS, and initial clinical trial results are promising.

READ MORE

Cellphone-microchip Duo Detects HIV

News

A portable and affordable mobile diagnostic tool detects HIV viruses and monitors its management in resource-limited regions, utilizing a cellphone and nanotechnology.

READ MORE

Cutting the Legs Off Cancer

News

Melanoma skin cancer tumors grow larger and are more likely to metastasize due to interactions between a pair of molecules, according to experiments in mice and human cells. The results may restore the potential for a type of cancer therapy previously abandoned in clinical trials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE